Pictilisib Enhances the Antitumor Effect of Doxorubicin and Prevents Tumor-Mediated Bone Destruction by Blockade of PI3K/AKT Pathway.

Liang C, Yu X, Xiong N, Zhang Z, Sun Z, Dong Y

Open source

DOI
10.3389/fonc.2020.615146
Published
2020
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2020.615146,
  title = {Pictilisib Enhances the Antitumor Effect of Doxorubicin and Prevents Tumor-Mediated Bone Destruction by Blockade of PI3K/AKT Pathway.},
  author = {Liang C and Yu X and Xiong N and Zhang Z and Sun Z and Dong Y},
  year = {2020},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2020.615146},
  url = {https://doi.org/10.3389/fonc.2020.615146}
}

RIS

TY  - JOUR
TI  - Pictilisib Enhances the Antitumor Effect of Doxorubicin and Prevents Tumor-Mediated Bone Destruction by Blockade of PI3K/AKT Pathway.
AU  - Liang C
AU  - Yu X
AU  - Xiong N
AU  - Zhang Z
AU  - Sun Z
AU  - Dong Y
PY  - 2020
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2020.615146
UR  - https://doi.org/10.3389/fonc.2020.615146
ER  - 

APA

C, L., X, Y., N, X., Z, Z., Z, S., & Y, D. (2020). Pictilisib Enhances the Antitumor Effect of Doxorubicin and Prevents Tumor-Mediated Bone Destruction by Blockade of PI3K/AKT Pathway.. Frontiers in oncology. https://doi.org/10.3389/fonc.2020.615146

Source records